Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Spectral Medical Inc.TSX: EDT.TO

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables turns negative

Q1 FY2026 accounts receivables was -CA$273K, compared with CA$141K a year earlier. Trailing-twelve-month accounts receivables was -CA$168K.

Context

  • Accounts receivables amounted to 10.1% of revenue in FY2025, down 1.5 pp from a year earlier.
  • Accounts receivables increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly accounts receivables holds near -CA$273K or moves back toward the trailing-twelve-month quarterly average of -CA$42K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$273K-219.7% QoQ
Last fiscal yearDec 2025
CA$246K+192.8% YoY
LTMMar 2026
-CA$168K-197.7% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-293.6%——
1 year+192.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

CAD · from the cash flow

Latest · FY2025
246K CAD
Year-over-year change
+192.8%
4-year CAGR
+45.4%

Accounts Receivables vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -197.7% is the 5th highest of 8, against a peer median of -76.8%.
  • Accounts receivables amounts to 6.1% of revenue for EDT.TO, versus a peer median of 8.2%.
EDT.TO Competitors
Accounts Receivables for EDT.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$34.55M CAD+870.4%—11.1%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$15.24M CAD-579.0%—22.9%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$8.15M CAD-224.8%—2.6%
PRN.TOProfound Medical Corp.LTM Mar 2026$3.48M USD-925.6%-55.1%18.6%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$2.72M USD-76.8%+100.4%5.3%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$1.98M USD+159.2%—3.9%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$406.45K USD+219.6%——
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$168K CAD-197.7%—6.1%
Peer median (excluding EDT.TO) —-76.8%+22.7%8.2%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(8.79M)(11.25M)(15.66M)(15.4M)(47.69M)
Depreciation & Amortization294K272K218K251K250K
Deferred Income Tax00000
Stock-Based Compensation1.26M1.2M1.49M1.68M2.12M
Change in Working Capital(1.76M)579K(406K)1.01M(189K)
Accounts Receivables55K(877K)870K(265K)246K
Inventory(51K)(47K)(26K)137K(148K)
Accounts Payables(1.11M)1.65M(267K)(51K)(265K)
Other Working Capital(656K)(142K)(983K)1.19M(22K)
Other Non-Cash Items288K(698K)3.64M3.64M33.88M
Operating Cash Flow(8.7M)(9.9M)(10.72M)(8.82M)(9.52M)
Capital Expenditures(483K)(33K)(185K)(27K)(195K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities158K0000
Investing Cash Flow(325K)(33K)(185K)(27K)(195K)
Debt Repayment(113K)3.71M3.93M9.74M9.67M
Common Stock Issued10M4.03M01.15M3.4M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities2.28M1.72M1.51M(2.02M)(155K)
Financing Cash Flow12.17M9.46M5.44M8.88M12.91M
Effect of Forex Changes(56K)0000
Net Change in Cash3.08M(476K)(5.46M)36K1.08M
Free Cash Flow(9.18M)(9.93M)(10.91M)(8.85M)(9.72M)

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.